We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Agios Pharmaceuticals
AGIO
$1.93B
| $8.36M | ﹤0.01% |
295,654
-62,322
| -17% | -$1.67M |
|
1577
Canadian National Railway
CNI
$76.6B
| $8.34M | ﹤0.01% |
+77,204
| New | +$9.2M |
|
|
HTO
1578
H2O America
HTO
$2.62B
| $8.32M | ﹤0.01% |
144,432
-75,377
| -34% | -$4.85M |
|
|
AAT
1579
American Assets Trust
AAT
$1.4B
| $8.3M | ﹤0.01% |
322,775
+48,914
| +18% | +$1.4M |
|
|
HTBK
1580
DELISTED
Heritage Commerce
HTBK
| $8.3M | ﹤0.01% |
731,599
-13,755
| -2% | -$158K |
|
1581
Assured Guaranty
AGO
$3.34B
| $8.29M | ﹤0.01% |
171,186
-8,216
| -5% | -$441K |
|
1582
Azenta
AZTA
$1.48B
| $8.28M | ﹤0.01% |
193,199
-91,716
| -32% | -$5.48M |
|
1583
Lazard
LAZ
$4.31B
| $8.27M | ﹤0.01% |
259,874
-13,802
| -5% | -$496K |
|
|
ARNC
1584
DELISTED
Arconic Corporation
ARNC
| $8.26M | ﹤0.01% |
484,645
+13,430
| +3% | +$348K |
|
|
DCH
1585
Dauch Corp
DCH
$1.51B
| $8.25M | ﹤0.01% |
1,208,500
-45,903
| -4% | -$413K |
|
|
GMS
1586
DELISTED
GMS Inc
GMS
| $8.25M | ﹤0.01% |
206,119
-18,718
| -8% | -$895K |
|
|
CHS
1587
DELISTED
Chicos FAS, Inc.
CHS
| $8.23M | ﹤0.01% |
1,700,901
+515,160
| +43% | +$2.86M |
|
1588
Live Oak Bancshares
LOB
$1.97B
| $8.18M | ﹤0.01% |
267,338
+9,412
| +4% | +$338K |
|
|
DNB
1589
DELISTED
Dun & Bradstreet
DNB
| $8.14M | ﹤0.01% |
656,633
+55,286
| +9% | +$820K |
|
|
CFLT
1590
DELISTED
Confluent
CFLT
| $8.13M | ﹤0.01% |
341,903
+89,349
| +35% | +$2.41M |
|
1591
BOK Financial
BOKF
$8.74B
| $8.12M | ﹤0.01% |
91,334
-3,197
| -3% | -$277K |
|
1592
PubMatic
PUBM
$810M
| $8.1M | ﹤0.01% |
487,111
+351,918
| +260% | +$6.36M |
|
1593
Atlantic Union Bankshares
AUB
$5.97B
| $8.1M | ﹤0.01% |
266,545
-6,199
| -2% | -$209K |
|
1594
Chegg
CHGG
$102M
| $8.1M | ﹤0.01% |
384,257
-5,021
| -1% | -$104K |
|
1595
Carter's
CRI
$1.47B
| $8.09M | ﹤0.01% |
123,496
-4,562
| -4% | -$349K |
|
1596
GlobalFoundries
GFS
$29.6B
| $8.06M | ﹤0.01% |
166,717
-337
| -0.2% | -$18.1K |
|
1597
Chesapeake Utilities
CPK
$3.21B
| $8.06M | ﹤0.01% |
69,841
-2,486
| -3% | -$322K |
|
|
AL
1598
DELISTED
Air Lease Corp
AL
| $8.03M | ﹤0.01% |
258,861
-24,451
| -9% | -$875K |
|
1599
Matsons
MATX
$6.18B
| $8.01M | ﹤0.01% |
130,253
-14,582
| -10% | -$1.12M |
|
1600
Canadian Pacific Kansas City
CP
$80.5B
| $8M | ﹤0.01% |
119,895
+89,125
| +290% | +$6.73M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.